A second impurity that is a classified as a probable human carcinogen has been found in valsartan, manufactured by Zhejiang Huahai Pharmaceuticals in China, Health Canada announces.
from CBC | Canada News https://ift.tt/2xgey6j
2nd possible carcinogen found in recalled blood pressure drug valsartan, Health Canada says
from CBC | Canada News https://ift.tt/2xgey6j
Related Posts:
NAFTA's Chapter 11 dispute mechanism too costly for Canada at $314M, says report- 'My nightmare is over,' says N.S. woman who faced deportation to childhood country
- Trudeau to unveil Canada's Olympic flag-bearer today
- Canadian Screen Awards 2018: Film, TV and digital media nominees unveiled
- Ottawa's new carbon pricing plan will reward clean companies
0 comments:
Post a Comment